- Home
- FRPH vs EYPT Comparison
FRPH vs EYPT Comparison
Compare FRPH & EYPT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FRPH
- EYPT
- Stock Information
- Founded
- FRPH 1986
- EYPT 1987
- Country
- FRPH United States
- EYPT United States
- Employees
- FRPH N/A
- EYPT N/A
- Industry
- FRPH Real Estate
- EYPT Biotechnology: Laboratory Analytical Instruments
- Sector
- FRPH Finance
- EYPT Industrials
- Exchange
- FRPH Nasdaq
- EYPT Nasdaq
- Market Cap
- FRPH 459.4M
- EYPT 967.4M
- IPO Year
- FRPH N/A
- EYPT 2005
- Fundamental
- Price
- FRPH $23.30
- EYPT $12.43
- Analyst Decision
- FRPH
- EYPT Strong Buy
- Analyst Count
- FRPH 0
- EYPT 5
- Target Price
- FRPH N/A
- EYPT $27.40
- AVG Volume (30 Days)
- FRPH 55.6K
- EYPT 1.4M
- Earning Date
- FRPH 11-05-2025
- EYPT 11-05-2025
- Dividend Yield
- FRPH N/A
- EYPT N/A
- EPS Growth
- FRPH N/A
- EYPT N/A
- EPS
- FRPH 0.28
- EYPT N/A
- Revenue
- FRPH $32,293,999.00
- EYPT $51,898,000.00
- Revenue This Year
- FRPH N/A
- EYPT N/A
- Revenue Next Year
- FRPH N/A
- EYPT N/A
- P/E Ratio
- FRPH $84.65
- EYPT N/A
- Revenue Growth
- FRPH 3.18
- EYPT 2.99
- 52 Week Low
- FRPH $22.95
- EYPT $3.91
- 52 Week High
- FRPH $33.00
- EYPT $14.91
- Technical
- Relative Strength Index (RSI)
- FRPH 36.87
- EYPT 49.96
- Support Level
- FRPH $22.95
- EYPT $11.55
- Resistance Level
- FRPH $24.80
- EYPT $12.47
- Average True Range (ATR)
- FRPH 0.61
- EYPT 0.79
- MACD
- FRPH -0.14
- EYPT 0.05
- Stochastic Oscillator
- FRPH 13.46
- EYPT 54.70
About FRPH FRP Holdings Inc.
FRP Holdings Inc is a holding company engaged in various real estate businesses. The company's business segments are Leasing and management of commercial properties owned by the company (the Industrial/Commercial Segment); Leasing and management of mining royalty land owned by the company (the Mining Royalty Lands Segment); real property acquisition, entitlement, development and construction for apartment, retail, warehouse, and office buildings either alone or through joint ventures (the Development Segment); ownership, leasing and management of buildings through joint ventures (the Multifamily Segment).
About EYPT EyePoint Pharmaceuticals Inc.
EyePoint Pharmaceuticals Inc is a pharmaceutical company. It is engaged in developing and commercializing ophthalmic products for the treatment of eye diseases. The company has developed FDA-approved sustained-release treatments in ophthalmology. Its pre-clinical development program is focused on using its core Durasert E and Verisome technology platforms to deliver drugs to treat wet age-related macular degeneration, glaucoma, osteoarthritis, and other diseases. Geographically, the firm has operational footprints in the U.S., China, and the UK. It generates a majority of its revenue from the U.S.